TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
INCR

InterCure Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic

5.40$ +1.9% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow INCR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – +220.6% +104.9% -204.6% – –
– – – – +187.7% +130.0% +14,043.5% +127.3% +58.2% +12.5% +16.7% +11.6%
– – -91.8% -74.2% +112,528.0% +729.1% -84.6% -35.5% +38.1% -70.9% -12.0% +6.5%
– – – – +125.2% -186.2% – -68.2% – – – –
– -237.0% – – – -171.9% – – – – – –
– – – +1,108.9% +0.0% -98.9% +2,084,000.0% -32.7% +40.7% -86.7% +67.1% -18.9%
– -1,144.3% +17.3% -79.4% +252.1% +384.5% -40.9% +186.5% +118.5% – +270.6% -111.3%
– – – – – – – – – – – –
– – – – +856.2% -105.8% +2,580.6% – +109.2% -145.0% – -476.2%
– +3,671.6% -7.2% -76.7% +271.1% +523.4% -61.8% +682.7% -39.2% -168.8% – -276.4%
– – -94.5% -396.2% – +1,751.3% -52.0% +1,400.8% -77.0% -461.4% – –
– – – – – – – – +186.8% -278.4% – –

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?